AIMEI HEALTH TECHNOLOGY CO
AFJKNASDAQ🏆 #4396 by market capUS Equity
$12.11▼ $0.48 (−3.81%)
Pre-market · at closeTrack AFJK
Get earnings, price moves & breaking news on Telegram
24h▼ 3.8%
7d▲ 0.0%
14d▲ 0.0%
30d▼ 4.6%
ytd▼ 81.7%
1y▲ 8.6%
🏦Market Cap
$38M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $12.11 – $12.11
- 52-Week Range
- $6.75 – $130.37
- Volume (shares)
- 100
- Avg Volume (shares)
- —
- Shares Outstanding
- 3.2M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- 92.6
- P/S Ratio
- —
- EPS (TTM)
- $0.08
- Dividend Yield
- —
- Dilution (1yr)
- −55.2%
AIMEI HEALTH TECHNOLOGY CO
AFJKFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$836K▼ −21.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$565K▼ −15.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
4.0M▼ −55.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$2M▼ −$2M YoY
StockOtter · stockotter.spaceAbout AIMEI HEALTH TECHNOLOGY CO
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.